Stay updated with breaking news from Ultivue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Sirona Dx, a technical contract research organization (CRO), providing advanced ....
Ultivue announces the addition of Steve Pemberton in the role of SVP Commercial Development, as the company adds to its growing executive team. Steve is a seasoned commercial executive with 25 years ....
Ultivue hat die Ernennung von zwei unabhängigen Vorstandsmitgliedern, Fenel Eloi und Mary Pat Lancelotta, bekannt gegeben. Fenel Eloi und Mary Pat Lancelotta sollen dabei helfen, die Marktstellung ....
Ultivue Announces New Executive Team Members in Research and Corporate Development Ultivue announces the addition of new executive team members in order to help strengthen its position as a leading assay development solutions provider for multiplex biomarker analysis for tissue phenotyping. Mike Sismour, PhD has joined Ultivue in the role of Vice President, Research, and Mark Rees, PhD has joined as Vice President, Corporate Development. Mike has a background enabling innovative solutions in the biotechnology and diagnostics industries. He brings extensive experience in nucleic acid chemistry/enzymology, in situ biomolecule detection, multiplexed biomolecule analysis, and sequencing system development. He was a NIH Ruth L. Kirschstein Postdoctoral Fellow at Harvard Medical School, a fellow at the Wyss Institute at Harvard, and most recently was Chief Scientist/Head of Genomics R&D at Beckman Coulter Life Science. ....